Vera Therapeutics, Inc. announced the appointment of Kerry Cooper, M.D., to the role of Senior Vice President, Medical Affairs, where he will report to Chief Medical Officer Celia Lin and be responsible for overseeing medical affairs strategy and scientific communications. Dr. Cooper brings nearly 40 years of experience in nephrology across a variety of senior positions within industry, clinical practice and academia. He has led medical affairs strategies for drug development programs in chronic kidney disease (CKD), hyperparathyroidism, hyperkalemia and other renal conditions.

Over twelve years, he served in leadership roles in medical affairs at several leading pharmaceutical companies, including AstraZeneca and Amgen, where he served as Global Medical Affairs Leader for Nephrology. He joins Vera from ProKidney, where he led the development of the medical affairs function. Dr. Cooper received his medical degree from Yale University and completed his residency and fellowship in nephrology at Yale's New Haven Hospital.

He previously served as an Associate Professor of Medicine at Yale University earlier in his career before transitioning to clinical practice and later industry roles. He has published numerous articles in peer-reviewed journals and has presented at national and international conferences.